1. Home
  2. PHGE vs VVPR Comparison

PHGE vs VVPR Comparison

Compare PHGE & VVPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • VVPR
  • Stock Information
  • Founded
  • PHGE 2015
  • VVPR 2014
  • Country
  • PHGE Israel
  • VVPR United Kingdom
  • Employees
  • PHGE N/A
  • VVPR N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • VVPR Power Generation
  • Sector
  • PHGE Health Care
  • VVPR Utilities
  • Exchange
  • PHGE Nasdaq
  • VVPR Nasdaq
  • Market Cap
  • PHGE 13.3M
  • VVPR 10.9M
  • IPO Year
  • PHGE N/A
  • VVPR 2016
  • Fundamental
  • Price
  • PHGE $0.74
  • VVPR $1.09
  • Analyst Decision
  • PHGE Strong Buy
  • VVPR
  • Analyst Count
  • PHGE 2
  • VVPR 0
  • Target Price
  • PHGE $13.50
  • VVPR N/A
  • AVG Volume (30 Days)
  • PHGE 110.1K
  • VVPR 679.2K
  • Earning Date
  • PHGE 11-14-2024
  • VVPR 01-01-0001
  • Dividend Yield
  • PHGE N/A
  • VVPR N/A
  • EPS Growth
  • PHGE N/A
  • VVPR N/A
  • EPS
  • PHGE N/A
  • VVPR N/A
  • Revenue
  • PHGE N/A
  • VVPR $16,000.00
  • Revenue This Year
  • PHGE N/A
  • VVPR N/A
  • Revenue Next Year
  • PHGE N/A
  • VVPR N/A
  • P/E Ratio
  • PHGE N/A
  • VVPR N/A
  • Revenue Growth
  • PHGE N/A
  • VVPR N/A
  • 52 Week Low
  • PHGE $0.48
  • VVPR $0.72
  • 52 Week High
  • PHGE $8.55
  • VVPR $9.90
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 54.26
  • VVPR 40.97
  • Support Level
  • PHGE $0.70
  • VVPR $1.08
  • Resistance Level
  • PHGE $0.80
  • VVPR $1.40
  • Average True Range (ATR)
  • PHGE 0.06
  • VVPR 0.17
  • MACD
  • PHGE 0.00
  • VVPR -0.05
  • Stochastic Oscillator
  • PHGE 41.18
  • VVPR 3.96

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About VVPR VivoPower International PLC

Vivopower International PLC is a solar power company. The company provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Critical Power Services segment which consists of the design, supply, installation, and maintenance of power and control systems. It provides its solutions to government, commercial, and industrial customers. Nearly all of the revenue derives from Australia.

Share on Social Networks: